ArticleBMC health services research2025
Global nexus of smoking prevalence, healthcare quality and respiratory cancer mortality: a cross-continental study.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmoking causes Trachea, Bronchus, and Lung Cancer (TBLC) mortality, depicting a strong correlation, while the quality of healthcare access in countries considerably impacts health outcomes. This study evaluates the differential effect in the interplay between Smoking Prevalence (SP) and health care, employing the Healthcare Access and Quality (HAQ) index towards the TBLC mortality rates across diverse continents and globally.
methodsThe data covering a 30-year period for 204 countries globally was categorised based on the level of SP (Low, Moderate, High, Critical) and the quality of healthcare access (Poor, Limited, Adequate, Optimal). A two-way ANOVA was utilised to analyse the patterns and variations in TBLC mortality rates across these categories, exploring the interactions between SP and the HAQ Index.
resultsDistinct patterns were observed in each continent, highlighting the complex interactions between the HAQ Index and SP, which lead to varying health outcomes. The results indicate that regions with an optimal HAQ Index and low SP have lower TBLC death rates, whereas those with a poor HAQ Index and critical SP exhibit higher death rates.
conclusionThe findings emphasise the need to address both smoking prevalence and healthcare facilities globally. By improving healthcare access and reducing smoking rates, governments can significantly lower TBLC mortality rates. This study underlines the importance of integrating public health policies that limit smoking prevalence with enhancements in healthcare systems to promote better health and well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.